Primary Site >> Colorectal Cancer

Gene >> GALNT3

Journal: Glycoconj J. 2010 Feb;27(2):267-76.
Title: Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
Author: Kato, Kentaro|Takeuchi, Hideyuki|Kanoh, Akira|Miyahara, Naoki|Nemoto-Sasaki, Yoko|Morimoto-Tomita, Megumi|Matsubara, Azusa|Ohashi, Yoshimi|Waki, Michihiko|Usami, Katsuaki|Mandel, Ulla|Clausen, Henrik|Higashi, Nobuaki|Irimura, Tatsuro
PMID: 20077002
Journal: J Cell Biochem. 2014 Feb;115(2):313-27.
Title: Clinically significant missense variants in human GALNT3, GALNT8, GALNT12, and GALNT13 genes: intriguing in silico findings.
Author: Hussain, Muhammad Ramzan M|Nasir, Jamal|Al-Aama, Jumana Yousuf
PMID: 24038392
Journal: Laryngoscope. 2017 Jan;127(1):70-78.
Title: Biological significance of genome-wide DNA methylation profiles in keloids.
Author: Jones, Lamont R|Greene, Joshua|Chen, Kang Mei|Divine, George|Chitale, Dhananjay|Shah, Veena|Datta, Indrani|Worsham, Maria J
PMID: 27312686
Journal: Biol Chem. 2018 Jun 27;399(7):649-659.
Title: Oncogenic BRAFV600E drives expression of MGL ligands in the colorectal cancer cell line HT29 through N-acetylgalactosamine-transferase 3.
Author: Sahasrabudhe, Neha M|Lenos, Kristiaan|van der Horst, Joost C|Rodriguez, Ernesto|van Vliet, Sandra J
PMID: 29894293